Is Bio Rad Laboratories Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NYSE: BIO) stock is to Strong Buy BIO stock.
Out of 3 analysts, 2 (66.67%) are recommending BIO as a Strong Buy, 1 (33.33%) are recommending BIO as a Buy, 0 (0%) are recommending BIO as a Hold, 0 (0%) are recommending BIO as a Sell, and 0 (0%) are recommending BIO as a Strong Sell.
What is BIO's forecast return on equity (ROE) for 2023-2024?
(NYSE: BIO) forecast ROE is 6.15%, which is considered weak.
What is BIO's Price Target?
According to 3 Wall Street analysts that have issued a 1 year BIO price target, the average BIO price target is $524.67, with the highest BIO stock price forecast at $525.00 and the lowest BIO stock price forecast at $524.00.
On average, Wall Street analysts predict that Bio Rad Laboratories's share price could reach $524.67 by Aug 7, 2024. The average Bio Rad Laboratories stock price prediction forecasts a potential upside of 43.97% from the current BIO share price of $364.42.
What is BIO's forecast return on assets (ROA) for 2023-2024?
(NYSE: BIO) forecast ROA is 4.34%, which is lower than the forecast US Medical Devices industry average of 9.69%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.